Corrigendum to “The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma” [Biomed. Pharmacother. 114 (2019) 108786]

Corrigendum to “The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma” [Biomed. Pharmacother. 114 (2019) 108786]

Bibliographic Details
Main Authors:	Yingying Zhang, Xingjing Li, Mudan He, Guoqing Zhang, Wuping Bao, Xia Fei, Xue Zhang, Min Zhang, Pengyu Zhang
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332220312105

Similar Items

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma
by: Yingying Zhang, et al.
Published: (2019-06-01)

Corrigendum to “Exosomes: An emerging factor in atherosclerosis” [Biomed. Pharmacother. 115 (2019) 108951]
by: Yanan Wang, et al.
Published: (2019-10-01)

Corrigendum to “Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma “in vitro” [Biomed. Pharmacother. 66 (2012) 64–69]
by: Erica Mie Akagi, et al.
Published: (2019-10-01)

Corrigendum to “Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro” [Biomed. Pharmacother. 109 (2019) 1016–1023]
by: Ningning Zhang, et al.
Published: (2020-10-01)

Monoclonal antibodies against the murine macrophage
by: Austyn, Jonathan M.
Published: (1980)

Corrigendum to “Luteolin, a flavonoid, as an anticancer agent: A review” [Biomed. Pharmacother. 112 (2019) 108612]
by: Muhammad Imran, et al.
Published: (2019-08-01)

Corrigendum to “Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats” [Biomed Pharmacother. 126 (2020) 110036]
by: Chunyue Yu, et al.
Published: (2020-08-01)

Corrigendum to “Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer” [Biomed Pharmacother. 97 (2018) 1275–1281]
by: Jiali Wu, et al.
Published: (2020-07-01)

Corrigendum to “SNHG11 contributes to NSCLC cell growth and migration by targeting miR-485-5p/BSG axis” [Biomed. Pharmacother. 128 (2020) 110324]
by: Ruirui Cheng, et al.
Published: (2020-12-01)

Heterohybridoma for the production of non murine monoclonal antibodies
by: Kh.Victoria Chanu and M. Ayub Ali
Published: (2010-01-01)

Monoclonal antibodies to murine methylcholanthrene induced sarcomas
by: Cohn, J. D.
Published: (1981)

Local glucocorticoid regulation in avian and murine lymphoid organs
by: Taves, Matthew D.
Published: (2015)

Corrigendum to “Nucleosome binding peptide presents laudable biophysical and in vivo effects” [Biomed. Pharmacother. 121 (2020) 109678]
by: Kaian Teles, et al.
Published: (2020-03-01)

Corrigendum to “miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells” [Biomed. Pharmacother. 84 (2016) 947–953]
by: Jing Wang, et al.
Published: (2020-08-01)

Corrigendum to ‘Proteomic changes in the hippocampus and motor cortex in a rat model of cerebral palsy: Effects of topical treatment’ [Biomed. Pharmacother. 133 (2021) 110844]
by: Tao Wang, et al.
Published: (2021-08-01)

Corrigendum to “Umbelliferone (7-hydroxycoumarin): A non-toxic antidiarrheal and antiulcerogenic coumarin” [Biomed. Pharmacother. 129 (2020) 110432]
by: Luisa Ferreira da Cruz, et al.
Published: (2020-10-01)

Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599]
by: Elmira Mohammadi, et al.
Published: (2021-08-01)

Corrigendum to “Nrf2 transcriptional activity in the mouse affects the physiological response to tribromoethanol” [Biomed. Pharmacother. 128 (2020) 110317]
by: Aleksandra Kopacz, et al.
Published: (2021-01-01)

Corrigendum to ‘Physiological and pathophysiological roles of Acidic mammalian chitinase (CHIA) in multiple organs’ [Biomed. Pharmacother. 138 (2021) 111465]
by: Chunli Hu, et al.
Published: (2021-07-01)

Corrigendum to “Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice” [Biomed. Pharmacother. 118 (2019) 109206]
by: Qiuke Hou, et al.
Published: (2019-10-01)

Corrigendum to “GJ-4 alleviates Aβ25-35-induced memory dysfunction in mice through protecting the neurovascular unit” [Biomed. Pharmacother. 127 (2020) 110131]
by: Zihong Zhang, et al.
Published: (2020-08-01)

The mechanism of glucocorticoid induced murine thymocyte and peripheral T cell apoptosis
by: Wang, Dapeng
Published: (2006)

Corrigendum to “MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway” [Biomed. Pharmacother. 118 (2019) 109111]
by: Wencui Wan, et al.
Published: (2020-11-01)

Corrigendum to “LncRNA SNHG16 reverses the effects of miR-15a/16 on LPS-induced inflammatory pathway” [Biomed. Pharmacother. 106 (2018) 1661–1667]
by: Wenying Wang, et al.
Published: (2021-01-01)

Corrigendum to “miR-152 regulated glioma cell proliferation and apoptosis via Runx2 mediated by DNMT1” [Biomed. Pharmacother. 92 (2017) 690–695]
by: Peng Zhang, et al.
Published: (2020-06-01)

A murine model of glucocorticoid myopathy alleviation using androgen therapy
by: Sandor, Nicolae Lucian
Published: (2016)

Corrigendum to “Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway” [Biomed. Pharmacother. 84 (2016) 1776–1782]
by: Shiqi Yuan, et al.
Published: (2020-02-01)

Corrigendum to ‘Innovated formulation of TCM pangolin scales to develop a nova therapy of rheumatoid arthritis’ [Biomed. Pharmacother. 126 (2020) 109872]
by: Huiqing Lv, et al.
Published: (2021-08-01)

Corrigendum to “Chrysin-nanoencapsulated PLGA-PEG for macrophage repolarization: Possible application in tissue regeneration” [Biomed. Pharmacother. 105 (2018) 773–780]
by: Akram Firouzi-Amandi, et al.
Published: (2019-10-01)

Corrigendum to “Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis” [Biomed. Pharmacother. 106 (2018) 813–820]
by: Shengli Wang, et al.
Published: (2019-03-01)

Corrigendum to “Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway” [Biomed. Pharmacother. 128 (2020) 110216]
by: Lihua Cui, et al.
Published: (2020-10-01)

Corrigendum to “Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion” [Biomed. Pharmacother. 82 (2016) 319–326]
by: Tinghong Ye, et al.
Published: (2019-12-01)

Humanization and characterization of an anti-human TNF-α murine monoclonal antibody.
by: Wei-Chun Chiu, et al.
Published: (2011-01-01)

Physiological studies of a murine hybridoma : growth and monoclonal antibody production
by: Scott, Michelle Frances
Published: (1990)

Development and characterization of murine monoclonal antibodies capable of neutralizing vaccinia virus
by: Chen, Ran
Published: (2007)

The Mechanism of Berberine Attenuation of Glucocorticoid Effects in Murine HEPA 1-6 Cells
by: Szu-Ying Huang, et al.
Published: (1997)

Retraction notice to “LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the β-catenin signaling pathway” [Biomed. Pharmacother. 108 (2018) 817–827]
by: Xian-Feng Zhang, et al.
Published: (2020-08-01)

Corrigendum to “Ac2-26 ameliorates lung ischemia-reperfusion injury via the eNOS pathway” [Biomed. Pharmacother. 117 (2019) 109194]
by: Jing Gong, et al.
Published: (2020-10-01)

Corrigendum to “New insights into long non-coding RNAs in non-small cell lung cancer” [Biomed. Pharmacother. 131 (November) (2020) 110775]
by: Ruifang Ye, et al.
Published: (2020-12-01)

Corrigendum to “Intrinsic β-catenin signaling suppresses CD8 + T-cell infiltration in colorectal cancer” [Biomed. Pharmacother. 115 (May) (2019) 108921]
by: Junli Xue, et al.
Published: (2020-12-01)